A proposal to end the Covid-19 pandemic
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
FRIDAY, MAY 20, 2022
FRIDAY, MAY 20, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
A proposal to end the Covid-19 pandemic

Coronavirus chronicle

Kristalina Georgieva, Gita Gopinath, and Ruchir Agarwal, IMF Blog
22 May, 2021, 06:30 pm
Last modified: 22 May, 2021, 06:42 pm

Related News

  • North Korea's Dr Fauci? Health official emerges as face of Covid campaign
  • Shanghai detects new infections after five days of 'zero Covid'
  • North Korea hails 'good results' on Covid as fever cases pass 2 million
  • IMF urges Asia to be mindful of spillover risks from tightening
  • China relaxes some Covid test rules for US, other travellers

A proposal to end the Covid-19 pandemic

The disparities will widen further between wealthy countries that have widespread access to vaccines, diagnostics, and therapeutics, and poorer countries still struggling to inoculate frontline healthcare workers

Kristalina Georgieva, Gita Gopinath, and Ruchir Agarwal, IMF Blog
22 May, 2021, 06:30 pm
Last modified: 22 May, 2021, 06:42 pm
Photo: IMF Blog
Photo: IMF Blog

Many countries have stepped up in the global fight against the pandemic, as have institutions such as the World Health Organization, the World Bank, Gavi (the Global Alliance for Vaccines and Immunization), the African Union, and others.

Yet, more than a year into the Covid-19 crisis, new cases worldwide are higher than ever. Urgent action is needed to arrest the rising human toll and economic strain.

As the IMF has warned, economic recoveries are diverging dangerously. The disparities will widen further between wealthy countries that have widespread access to vaccines, diagnostics, and therapeutics, and poorer countries still struggling to inoculate frontline healthcare workers. As of the end of April 2021, less than two percent of Africa's population had been vaccinated. By contrast, over 40 percent of the population in the United States and over 20 percent in Europe had received at least one dose of the vaccine.

It is well understood that there can be no lasting end to the economic crisis without an end to the health crisis. Pandemic policy is thus economic policy. It is critical for global macroeconomic and financial stability, which makes it of fundamental importance to the IMF and other economic institutions. Ending the pandemic is a solvable problem but requires further coordinated global action.

The latest research by IMF staff analyzes multiple dimensions of the fight against the pandemic and proposes realistic targets to bring the pandemic substantially under control everywhere—and the means to achieve them. Building on the work of other agencies, the proposal aims to:

  • vaccinate at least 40 percent of the population in all countries by the end of 2021 and at least 60 percent by the first half of 2022,
  • track and insure against downside risks, and
  • ensure widespread testing and tracing, maintain adequate stocks of therapeutics, and enforce public health measures in places where vaccine coverage is low.

Importantly, the strategy requires not just commitments but upfront financing, upfront vaccine donations, and "at-risk" investment for the world to insure against downside scenarios.

The proposal's total cost of around $50 billion would include grants, national government resources, and concessional financing.

There is a strong case for grant financing of at least $35 billion. The good news is G20 governments have already identified as important to address the $22 billion grant funding gap noted by the Access to Covid-19 Tools (ACT) Accelerator. This leaves an estimated $13 billion in additional grant contributions needed.

The remainder of the overall financing plan—around $15 billion—could come from national governments, potentially supported by Covid-19 financing facilities created by multilateral development banks.

Saving lives and livelihoods should need no justification, but a faster end to the pandemic could also inject the equivalent of $9 trillion into the global economy by 2025 due to a faster resumption of economic activity. Advanced economies, likely to spend the most in this effort, would see the highest return on public investment in modern history—capturing 40 percent of the cumulative $9 trillion in global GDP gains and roughly $1 trillion in additional tax revenues.

Recommendations for action

The key proposed steps include:

Achieving the vaccination targets

1. Provide additional upfront grants to Covax of at least $4 billion. This financing will help finalize orders and activate unused vaccine capacity.

2. Ensure free cross-border flows of raw materials and finished vaccines: Such restrictions are jeopardizing access to vaccines for billions of people in the developing world.

3. Immediately donate surplus vaccines: We project at least 500 million vaccines courses (equivalent to around 1 billion doses) can be donated in 2021, even if countries give preference to their own populations. Donations, including for delivery costs, should be done through Covax so vaccines are shared on equitable and public health principles.

We project the measures identified in steps 1–3 may be sufficient to achieve the 40 percent vaccination target by the end of 2021 and the 60 percent target by the first half of 2022, if no downside risks materialize.

Insuring against downside risks

4. Make at-risk investments to diversify and increase vaccine production capacity by 1 billion doses in early 2022 to handle downside risks in 91 low- and middle-income countries, including from new variants that may require booster shots. [$8 billion]

5. Scale up genomic surveillance and systemic supply chain surveillance with concrete contingency plans in place to handle possible mutations or shocks to the supply chain. These plans should be prepared with the participation of multilateral agencies, vaccine developers and manufacturers, and key national governments. [$3 billion]

Managing the interim period when vaccine supply is limited

6. Ensure widespread testing, sufficient therapeutics, public health measures, and prepare for vaccine deployment . [$30 billion]

7. Urgently evaluate and implement (where approved) dose stretching strategies to expand effective supply. [$2 billion]

Additional needed measures account for $3 billion. Steps 4–7 are needed to insure against downside risks, and to mitigate the health consequences of the pandemic in the interim period.

The proposal complements the work of the G20 High Level Independent Panel, the G7 Pandemic Preparedness Partnership group, and the Report of the Independent Panel for Pandemic Preparedness and Response, which primarily focus on addressing future pandemics. This proposal focuses on what is needed to bring the current pandemic under control. To make it effective, countries need to work together.

The world does not have to live through the pain of another record surge of Covid-19 cases. With strong global action now and with very little in terms of financing relative to the outsized benefits, we can durably exit this health crisis.


Kristalina Georgieva is the Managing Director of the International Monetary Fund

Gita Gopinath is the Economic Counsellor and Director of the Research Department at the International Monetary Fund (IMF)

Ruchir Agarwal is an Economist at the IMF


Disclaimer: This article first appeared on IMF Blog and is published by special syndication arrangement.

Top News

IMF Blog / IMF / pandemic / COVID-19 / Coronavirus Pandemic

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Infographic: TBS
    Businesses reel under soaring costs
  • Photo: Mumit M/TBS
    What delays infrastructure projects in Bangladesh?
  • What needs to be done now?
    What needs to be done now?

MOST VIEWED

  • Ryu Yong Chol, an official at North Korea's state emergency epidemic prevention headquarters, speaks during a daily coronavirus program on state-run television KRT, in this still image obtained from KRT footage released on May 20, 2022. REUTERS TV/KRT via REUTERS
    North Korea's Dr Fauci? Health official emerges as face of Covid campaign
  • Workers in protective suit spray disinfectant at a community, during the lockdown to curb the spread of the coronavirus disease (COVID-19) in Shanghai, China, April 5, 2022. REUTERS/Aly Song
    Shanghai detects new infections after five days of 'zero Covid'
  • Volunteers carry out temperature screening during an anti-virus campaign in Pyongyang, North Korea in this image released by North Korea's Korean Central News Agency (KCNA) on March 4, 2020. KCNA via REUTERS/File Photo
    North Korea hails 'good results' on Covid as fever cases pass 2 million
  • Medical staff members check the temperature of people as they enter at Capital Airport, following an outbreak of Covid-19, in Beijing, China, 5 November, 2020. Photo: Reuters
    China relaxes some Covid test rules for US, other travellers
  • Representational image.
    China Junshi's potential Covid drug shows promise in small trial
  • A woman wearing protective mask walks at a sidewalk near business district in Jakarta, Indonesia March 2, 2020. REUTERS/Willy Kurniawan/Files
    Indonesia to drop outdoor mask mandate as Covid-19 infections drop

Related News

  • North Korea's Dr Fauci? Health official emerges as face of Covid campaign
  • Shanghai detects new infections after five days of 'zero Covid'
  • North Korea hails 'good results' on Covid as fever cases pass 2 million
  • IMF urges Asia to be mindful of spillover risks from tightening
  • China relaxes some Covid test rules for US, other travellers

Features

Professor Mustafizur Rahman. Illustration: TBS

Project delays and escalating costs are driven by frequent revisions and lack of good governance

1h | Panorama
Photo: Mumit M/TBS

What delays infrastructure projects in Bangladesh?

1h | Panorama
Foods that you should never put in the refrigerator

Foods that you should never put in the refrigerator

2h | Food
Beef Kunafa: A treat for beef and cheese lovers

Beef Kunafa: A treat for beef and cheese lovers

2h | Food

More Videos from TBS

Gazipur restaurant that serves 150 food items

Gazipur restaurant that serves 150 food items

2h | Videos
How to prepare for a job

How to prepare for a job

3h | Videos
Putin's strategies to face Nato

Putin's strategies to face Nato

15h | Videos
How many countries have nuclear weapons and how many are there?

How many countries have nuclear weapons and how many are there?

15h | Videos

Most Read

1
Tk100 for bike, Tk2,400 for bus to cross Padma Bridge
Bangladesh

Tk100 for bike, Tk2,400 for bus to cross Padma Bridge

2
Representative Photo: Pixabay.
Bangladesh

Microplastics found in 5 local sugar brands

3
Mushfiq Mobarak. Photo: Noor-A-Alam
Panorama

Meet the Yale professor who anchors his research in Bangladesh and scales up interventions globally

4
A packet of US five-dollar bills is inspected at the Bureau of Engraving and Printing in Washington March 26, 2015. REUTERS/Gary Cameron
Banking

Dollar hits Tk100 mark in open market

5
The story of Bangladesh becoming a major bicycle exporter
Industry

The story of Bangladesh becoming a major bicycle exporter

6
PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire
Crime

PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab